Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by DocMaillouxon Jan 11, 2018 7:56am

96 Views

Post# 27331758

RE:looking at chart. Might fall to 0.27cents

Strong support at .34 might briefly flush to .31-.33 o close the gap but something big is brewing that chart aint setting up for nothing and it was a controlled setup to have it break down under that 42-45 support ... The big guys wanted to load more cheaper .. very easy to have it trade down to the 20 ma when the Weed market is full of newbie traders who dont know SH1t and follow a J Hooker Chart reader

Bullboard Posts

This junior mining stock offers billions in market exposure